ArticleBlood advances2021

Gilteritinib-induced upregulation of S100A9 is mediated through BCL6 in acute myeloid leukemia.

Megan E Zavorka Thomas et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.